Clinical Trials Browser

Phase 3 × Venous Thromboembolism × Dabigatran × Clear all

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Phase 3 Unknown

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism